Dear Dr. Tan, Thank you for your interest in our article. We agree that it would be informative to compare the rates of endophthalmitis between patients who did not receive intracameral cefuroxime (ICC) and those that did. As stated in the article, we did not use ICC prior to 2006 and the vast majority of patients received ICC after 2008 since it became our prophylactic treatment policy.
Upon your suggestion, we compared the rates of endoph- Three cases of endophthalmitis occurred between 2010 and 2014 in patients that received ICC. As stated above, it is reasonable to assume that the majority of patients received ICC after 2009 at the end of cataract surgery. Of course, this does not fully protect against endophthalmitis. Unfortunately, we cannot report the exact number of patients that did not receive ICC since 2009.
We can only speculate on the difference in the type of organisms of the culture-positive endophthalmitis following the period of the use of ICC. Yet some of the patients that developed endophthalmitis after 2009 did not receive ICC at the end of the cataract surgery due to various reasons that we reported on. Indeed, the difference might be because of better coverage of some of the organisms by the antibiotic injection leading to higher rates of Gram-negative cultures. We feel that the low number of cases prevents us from currently drawing these conclusions.
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